Saúde Pública/Medicina Humanitária

Revisão | Acessibilidade global a medicamentos para diabetes melito.

14 Fev, 2022 | 15:41h

Global accessibility of therapeutics for diabetes mellitus – Nature Reviews Endocrinology (se o acesso a este link for pago, tente este)

Conteúdo relacionado:

New WHO report maps barriers to insulin availability and suggests actions to promote universal access – “100 years after its discovery, insulin still out of reach for many living with diabetes”.

Editorial | Insulin for all: a hope yet to be realized.

One hundred years of insulin therapy.

The state of diabetes treatment coverage in 55 low-income and middle-income countries – fewer than one in ten people with diabetes in LMICs receive comprehensive care such as low-cost medicines to reduce blood sugar, blood pressure and cholesterol levels, in addition to counseling on diet, exercise and weight.

---

Entrevista em áudio: Covid-19 como doença endêmica.

11 Fev, 2022 | 14:22h

Audio Interview: Covid-19 as an Endemic Disease – New England Journal of Medicine

---

Bebês nascidos durante o primeiro ano da pandemia tiveram um escore levemente menor em testes de avaliação de desenvolvimento.

11 Fev, 2022 | 14:21h

Comunicado de imprensa: Babies born during pandemic’s first year score slightly lower on a developmental screening test – Columbia University Irving Medical Center

Estudo original: Association of Birth During the COVID-19 Pandemic With Neurodevelopmental Status at 6 Months in Infants With and Without In Utero Exposure to Maternal SARS-CoV-2 Infection – JAMA Pediatrics

Editorial: Understanding the Effects of the Pandemic on Infant Development—The Preterm Problem

Comentários:

Covid-19: Babies born during the pandemic show slight development delays – The BMJ

Pandemic birth tied to poor development – CIDRAP

---

Estratégias de controle da escabiose na comunidade: um estudo randomizado mostrou que uma dose de ivermectina foi não inferior a duas doses (intervalo de 7 a 14 dias) na redução da prevalência da doença em 12 meses.

11 Fev, 2022 | 14:17h

Community control strategies for scabies: A cluster randomised noninferiority trial – PLOS Medicine

Comunicado de imprensa: One dose of anti-parasite drug just as effective as two at reducing scabies – Murdoch Children’s Research Institute

---

M-A | Prevalência da solidão em 113 países.

10 Fev, 2022 | 13:57h

The prevalence of loneliness across 113 countries: systematic review and meta-analysis – The BMJ

Editorial: We need a public health approach to loneliness

Comunicado de imprensa: Problematic levels of loneliness widespread in many countries – BMJ

 

Comentário no Twitter

Our latest paper in @bmj_latest shows that problematic levels of #loneliness is common on a global scale. Well done to the team, especially the talented #PhD student @DanielSurkalim who led this work with @DrMelodyDing. What a great publication. Watch this talent. #endloneliness https://t.co/zhdvE6JKaT

— Dr Robert Eres (@robert_eres) February 10, 2022

 

---

Suécia suspende testagem de rotina para COVID-19 e retira as restrições devido a pandemia – “Somente profissionais da saúde e cuidadores de idosos, além dos mais vulneráveis, serão aptos a fazer teste de PCR gratuito se estiverem sintomáticos, enquanto o restante da população será orientado somente a permanecer em casa se apresentarem sintomas sugestivos de COVID-19.”

10 Fev, 2022 | 13:56h

Sweden ends COVID-19 testing as pandemic restrictions lifted – Associated Press

Conteúdos relacionados:

How Denmark Decided COVID Isn’t a Critical Threat to Society – “The country became the first in the EU to lift all COVID restrictions despite leading the world in per capita infections”.

Covid: Europe set for ‘long period of tranquillity’ in pandemic, says WHO.

As Denmark scraps COVID restrictions, WHO urges caution.

Despite the ongoing spread of Omicron, some European countries have decided to lift Covid-19 restrictions.

---

Um estudo de base populacional no Catar mostrou que infecção prévia fornece proteção robusta contra reinfecção pelas variantes Alfa, Beta e Delta do SARS-CoV-2 (cerca de 90%). No entanto, a proteção contra reinfecção pela variante Ômicron foi menor (em torno de 60%).

10 Fev, 2022 | 13:54h

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection – New England Journal of Medicine

 

Comentário no Twitter

Using a national database in Qatar, investigators found that previous #SARSCoV2 infection provided protection against reinfection that ranged from 85% to 92% for alpha, beta, and delta strains and was approx 60% protective against omicron. #COVID19 https://t.co/SGODYCmkP3 pic.twitter.com/OkgjCbyZBj

— NEJM (@NEJM) February 9, 2022

 

---

Estudo randomizado | Análise final de eficácia e segurança da vacina de dose única da J&J.

10 Fev, 2022 | 13:53h

Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S – New England Journal of Medicine

 

Comentário no Twitter

A single injection of the Ad26.COV2.S Covid-19 vaccine showed 56.3% vaccine efficacy beginning 14 days after injection and 52.9% efficacy more than 28 days after injection against moderate to severe–critical #COVID19. #IDTwitter https://t.co/0VhaEUtmwq pic.twitter.com/04QqSyYwNI

— NEJM (@NEJM) February 9, 2022

 

---

Efetividade da vacinação heteróloga com CoronaVac e Pfizer no Brasil.

10 Fev, 2022 | 13:51h

Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil – Nature Medicine

 

Comentário no Twitter

An analysis of data from Brazil in @NatureMedicine shows that vaccine effectiveness against SARS-CoV-2 infection and severe COVID-19 outcomes declines after two doses of CoronaVac but increases after a booster dose of the Pfizer-BioNTech vaccine. https://t.co/UCgy6cJFIP pic.twitter.com/pXvkxZHXvv

— Nature Portfolio (@NaturePortfolio) February 9, 2022

 

---

Revisão sistemática | Uso excessivo de testes na atenção à saúde.

10 Fev, 2022 | 13:45h

Overuse of diagnostic testing in healthcare: a systematic review – BMJ Quality & Safety

---